Literature DB >> 23756049

Hepatogenesis of murine induced pluripotent stem cells in 3D micro-cavitary hydrogel system for liver regeneration.

Ting Ting Lau1, Li Wen Ho, Dong-An Wang.   

Abstract

The discovery of induced pluripotent stem cell (iPSC) technology has raised hopes in circumventing the current limitations in cell-based therapies where autologous stem cells could be generated from terminally differentiated somatic cells. Given the relatively short history of iPSC research, most of the studies are scientific exploratory in nature and hence have minimal practical usage. In this study, we aimed to combine existing knowledge on iPSC differentiation with three-dimensional (3D) scaffold platform so as to fabricate implantable constructs for liver regeneration. A micro-cavitary hydrogel (MCG) platform was employed as a continuous system for both colonies and/or EBs formation and differentiation. The advantage of MCG system is that it further enhances nutrient exchange and also permits greater living space for the encapsulated pluripotent stem cells to rapidly grow into colonies and/or EBs compared to typical non-MCG system. Murine iPSCs and embryonic stem cells (ESCs) were encapsulated respectively in alginate MCG system and after culturing for 10 days; colonies/EBs were formed spontaneously. Differentiation conditions were then introduced to direct the cells toward endodermal lineage and subsequently hepatic lineage and maturation. Up-regulation of endoderm markers and hepatic markers was observed in both iPSCs and ESCs suggesting that iPSC as effectively as the ESCs in MCG system. Urea and albumin production were significantly higher compared to monolayer culture, demonstrating the beneficial effects of MCG system. The results from this work provide foundation in understanding of iPSC differentiation in 3D engineered environment and aid in future biomedical research of iPSC technology.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23756049     DOI: 10.1016/j.biomaterials.2013.05.034

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  7 in total

Review 1.  Application of biomaterials to advance induced pluripotent stem cell research and therapy.

Authors:  Zhixiang Tong; Aniruddh Solanki; Allison Hamilos; Oren Levy; Kendall Wen; Xiaolei Yin; Jeffrey M Karp
Journal:  EMBO J       Date:  2015-03-12       Impact factor: 11.598

Review 2.  Effects of age at Kasai portoenterostomy on the surgical outcome: a review of the literature.

Authors:  Masaki Nio; Motoshi Wada; Hideyuki Sasaki; Hiromu Tanaka
Journal:  Surg Today       Date:  2014-09-12       Impact factor: 2.549

Review 3.  In vitro culture of isolated primary hepatocytes and stem cell-derived hepatocyte-like cells for liver regeneration.

Authors:  Chenxia Hu; Lanjuan Li
Journal:  Protein Cell       Date:  2015-06-19       Impact factor: 14.870

Review 4.  Stem Cell Strategies to Evaluate Idiosyncratic Drug-induced Liver Injury.

Authors:  Winfried Krueger; Urs A Boelsterli; Theodore P Rasmussen
Journal:  J Clin Transl Hepatol       Date:  2014-09-15

Review 5.  Stem cell therapy and tissue engineering strategies using cell aggregates and decellularized scaffolds for the rescue of liver failure.

Authors:  Jiabin Zhang; Hon Fai Chan; Haixia Wang; Dan Shao; Yu Tao; Mingqiang Li
Journal:  J Tissue Eng       Date:  2021-02-01       Impact factor: 7.813

Review 6.  Two Effective Routes for Removing Lineage Restriction Roadblocks: From Somatic Cells to Hepatocytes.

Authors:  Chenxia Hu; Lanjuan Li
Journal:  Int J Mol Sci       Date:  2015-09-01       Impact factor: 5.923

Review 7.  Regulated differentiation of stem cells into an artificial 3D liver as a transplantable source.

Authors:  Feng Chen; Hua Wang; Jia Xiao
Journal:  Clin Mol Hepatol       Date:  2020-02-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.